NFE2L2 and breast carcinoma: The ability of SFN to decrease Nrf2 activity in breast cancer cells is beneficial from the point of view of cancer therapy, while its ability to increase Nrf2 activity in normal breast cells provides an useful and effective tool for cancer prevention.